Sanofi touts survival data on cancer drug Zaltrap; Spectrum wins patent extension on Folotyn;

@FiercePharma: A head-scratcher for SEC: Pfizer reports U.S. loss, $15B in overseas profits. More | Follow @FiercePharma

> Sanofi ($SNY) said new data showed that its cancer drug Zaltrap improved overall survival and progression-free survival in patients with metastatic colon cancer. Report

> Sanofi said it would spend $70 million to buy back contingent value rights related to last year's buyout of Genzyme. Report

> Spectrum Pharmaceuticals ($SPPI) won a 5-year extension to its patent on the cancer drug Folotyn, used to treat peripheral T-cell lymphoma, to 2022. Report

> Pfizer ($PFE) said it would appeal India's ruling against patent protection for its kidney and liver cancer drug Sutent. Report

> An Indian securities board upheld insider trading charges against former Ranbaxy Laboratories director VK Kaul and his wife Bala Kaul. Report

> Pakistani drugmakers are complaining to the government about opening the domestic market to Indian imports. Report

Biotech News

 @FierceBiotech: ACRO decries TV portrayal of clinical. More | Follow @FierceBiotech

 @JohnCFierce: Honey, we shrunk the biotech: Targacept cuts back (again). Release | Follow @JohnCFierce

 @RyanMFierce: Life Technologies bought a bioinformatics group, Compendia, a U of Mich. spinoff. Terms undisclosed. More | Follow @RyanMFierce

> Stem cell pioneers win this year's Nobel prize for medicine. Story

> AstraZeneca bags PhIIb-ready CKD drug in $272M Ardelyx partnership. Article

> Troubled Targacept whacks laboratory ops in latest restructuring. News

Medical Device News

 @FierceMedDev: U.S. regulators are worried about an off-label use of stents or balloons to treat MS. More | Follow @FierceMedDev

 @MarkHFierce: CareFusion acquires a Brazilian respiratory company. More | Follow @MarkHFierce

 @DamianFierce: Olympus Biotech is tossing its hat into the CMO ring. More | Follow @DamianFierce

> Wright looks to turn the page on kickback scandal. Story

> FDA issues safety alert for Stryker fluid drainage device. Item

CRO News

> Quintiles looks to Scotland for clinical trial growth. Article

> Icon partners with Korean CRO group. More

> Catalent, Parexel team up for trial supply. News

> Olympus Biotech jumps into CMO game. Story

Biotech IT News

> Oracle, IBM support $100M personalized medicine effort at UPMC. Article

> Biotech billionaire's supercomputer cuts cancer analysis to 47 seconds. Story

> 'Big Data' startup wins deal with Aptalis Pharma. More

And Finally... An online pharmacy that sold counterfeit cancer drugs to U.S. doctors switched its registration as FDA sought to crack down on the company's websites. Report

Suggested Articles

Stephen Hahn, an oncologist who served as the chief medical officer for the MD Anderson Cancer Center, has secured Senate confirmation as FDA head.

As BMS searches for bright spots in its Opdivo-chemo combo fail from June, it’s zeroing in on squamous lung cancer patients who seemed to benefit.

The FDA's ad watchdog served its most serious violation to Alkermes Wednesday—and it took the unusual step of announcing that violation to the world.